Huakang Gene Research Institute (HKGRI)
Huakang Gene Research Institute (GRI)
China’s national-level leader in genetic counseling education and clinical genomics research
About Us
Huakang Gene Research Institute (HKGRI) is a non-profit research institution officially registered with the Beijing Municipal Civil Affairs Bureau (Registration No. 0030326). Founded in 2011 and headquartered in Zhongguancun, Beijing’s leading science and technology hub, HKGRI is dedicated to genomic technology research, clinical translation, and industrial innovation.
The Institute operates a licensed medical testing laboratory equipped with advanced genomics platforms and international-standard instrumentation. Our proprietary BestSeq™ technology platform delivers accurate, cost-effective, and high-throughput detection of hundreds of pathogenic genes. These include panels for epilepsy, intellectual disability, and other genetic conditions. BestSeq™ has already been applied in clinical collaborations with leading hospitals such as Peking University First Hospital.
Under the leadership of President Wei Wei, HKGRI brings together a research team that includes internationally trained scientists with experience in top institutions across Europe, the U.S., and Asia. The team has published in journals such as Science and Circulation, and completed landmark projects in genetic testing for hypertrophic cardiomyopathy and amyotrophic lateral sclerosis (ALS). To date, HKGRI has developed over 1,500 genetic diagnostic products spanning cardiovascular disease, oncology, neurology, and rare disorders.
Our Vision
To advance the diagnosis, treatment, and prevention of genetic diseases by bridging international standards with China’s unique clinical resources.
Key Initiatives
Genetic Counseling Education
The only accredited national-level training programs for genetic counselors in China.
Professional Development
Continuing education for clinicians, harmonized with NSGC/ABGC/ACGC frameworks.
Youth Genomics Education
Bootcamps and outreach programs for Chinese high school students.
Research Collaborations
Longitudinal patient datasets enabling new insights into polygenic risk, cancer genomics, and rare diseases.
Our Board
Mr. Wei Wei
President of HKGRI
Dr. Xue Zhang
President, Harbin Medical University
Member of the Chinese Academy of Engineering
Mr. Tony Chan
Former Chancellor, Hong Kong University of Science and Technology; Founding President, KAUST
Huakang is inviting global experts to join our Advisory Board to guide education, research, and international collaboration.
Our Research
Huakang Gene Research Institute is located in the core of Beijing Zhongguancun Science Park. For more than a decade, the Institute has focused on molecular medicine research and clinical diagnostics, operating a licensed laboratory specializing in cellular and molecular genetics.
Through its technical expertise, HKGRI has partnered with leading hospitals to carry out projects on hundreds of single-gene disorders across multiple medical specialties. Many of these initiatives have filled critical gaps in China’s clinical practice and now stand at an internationally leading level.
The Institute’s BestSeq™ pathogenic gene detection technology, based on high-throughput sequencing with optimized target capture, combines accuracy, efficiency, and cost-effectiveness. It is emerging as a new-generation platform for genetic and disease research worldwide.
Publications & Recognition
Science
Journal of Clinical Investigation (JCI)
Oncogene
Circulation
National accreditation by the Ministry of Human Resources and Social Security of China for genetic counseling education.